Product Images Clopidogrel

Each tablet of this medication contains 97.875mg of clopidogrel bisulfate, USP, which is equal to 75mg of clopidogrel base. It is a drug used for anti-platelet therapy. The usual adult dosage and detailed information about the medication can be found in the package insert and the Medication Guide. The tablets are stored between 20 to 25 °C (68 to 77 °F), with excursions permitted up to 15 to 30 °C (59 to 86 °F). It’s advisable to contact the pharmacist and to obtain the medication guide for each individual patient through the NorthStar website or by calling the provided number. The medication has been manufactured by Matleods Pharmaceuticas Ltd for NorthStar RX LLC.*

Each tablet contains 97.875 mg of clopidogrel bisufate, USP, which is equivalent to 75 mg of clopidogrel base. The tablets are meant for adult use and should be stored at 20° to 25°C (68° to 77° F). They should be dispensed with a medication guide either available at the manufacturer's website or provided to each patient separately. The drug is manufactured by Macleods Pharmaceuticals Ltd in India, for Northstar Hedhoar Holdngs. The package contains 500 tablets.*

This is a description of a medication containing clopidogrel bisulfate, with each tablet equivalent to 75 mg of clopidogrel base. The usual adult dosage is not provided and should be consulted in the package insert. The tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), with excursion to 15°C to 30°C permitted. The pharmacist should dispense the medication with the Medication Guide provided. The product is available in a pack of 90 tablets and is manufactured in India. More information can be found on the manufacturer's website or by contacting them directly.*

The text describes a comparison between two treatments, Placebo with aspirin and Clopidogrel with aspirin, where the statistic value of the comparison result is 0.00009. The comparison was carried out for 12 months of follow-up, and other standard therapies were also used alongside the treatments as needed.*

This text appears to be a statistical analysis of the efficacy and mortality rates of a drug called Clopidogrel compared to a placebo. The study included patients who received aspirin and were followed for up to 28 days, with the Clopidogrel group experiencing a 7% risk reduction in mortality compared to the placebo group. The text also includes the total number of deaths in each group and the percentage of deaths in each group.*

This appears to be a table or a graph with three columns. The first two columns list two drug names, aspirin and clopidogrel. The third column contains a numerical value of 0.045 next to the letter "P." There is also a header above the columns indicating that the data may be related to months of follow-up. Without further context, it is difficult to provide a more useful description.*

This text appears to be a table of data related to a medication called Clopidogrel. The table consists of a list of numbers and some other labels such as Placebo. The purpose of the table is not clear from this text.*